Press release
Global Sartans Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Sartans Market Growth
How Big Is the Sartans Market Size Expected to Be by 2034?
The sartans market has experienced a consistent growth over the recent years. It is forecasted to expand from $21.36 billion in 2024 to $22.39 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.8%. The notable growth in the historical period can be credited to the rise in sedentary lifestyles, growing obesity rates, heightened awareness of cardiovascular diseases, increased healthcare spending, and the surging demand for generic antihypertensive medications.
In the coming years, the market size of sartans is predicted to experience consistent expansion, ballooning to $26.66 billion by 2029 with a compound annual growth rate (CAGR) of 4.5%. This growth during the projected period is attributable to the escalating attention on combination treatments, increased funding in pharmaceutical research and development, surge in demand from emerging markets, growth of healthcare infrastructure, and a higher incidence of lifestyle-related illnesses. The forecast period is also expected to see significant trends such as improvements in drug delivery technologies, enhanced production processes for Active Pharmaceutical Ingredients (APIs), the inception of fixed-dose combination medications, innovation in custom hypertension treatment, and the creation of new sartan derivatives.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp
What Are the Emerging Segments Within the Sartans Market?
The sartans market covered in this report is segmented -
1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp
What Long-Term Drivers Are Shaping Sartans Market Trends?
The upward trend in hypertensive conditions is set to stimulate expansion in the sartans market. Identified by continuous high blood pressure, hypertension heightens the risk of heart disease, stroke, and other serious health issues. The escalating number of hypertension cases corresponds with salt and processed food-heavy diets, which result in fluid accumulation and amplified stress on the heart. Sartans mitigate hypertension by preventing angiotensin II, a hormone that constricts blood vessels. This serves to relax and widen these vessels, thereby reducing blood pressure and minimizing strain on the heart. In January 2024, the American Heart Association, a nonprofit organization based in the US, reported that there were 131,454 deaths primarily due to high blood pressure in 2022, marking a rise from 124,508 deaths in 2021. Consequently, the increased frequency of hypertension cases is fueling the progress of the sartans market.
Who Are the Top Competitors in Key Sartans Market Segments?
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.
What Are the Major Trends Shaping the Sartans Market?
Leading enterprises in the sartans market are strategizing their growth by innovating and enhancing products, particularly sartans in tablet form, to improve patient compliance and therapeutic effectiveness. Sartan tablets are orally administered medications that contain sartan drugs designed to obstruct angiotensin II's impacts, inducing blood vessel relaxation and diminishing blood pressure. For instance, in July 2024, the US FDA approved Valsartan Tablets USP (40 mg, 80 mg) manufactured by the Indian pharmaceutical firm, Zydus Lifesciences. Sold under the trademark name Diovan, these tablets are employed to manage heart failure and hypertension, increase survival chances after a heart attack in adults, and are also appropriate for children aged over one year.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/sartans-global-market-report
Which Regions Are Becoming Hubs for Sartans Market Innovation?
North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Sartans Market?
2. What is the CAGR expected in the Sartans Market?
3. What Are the Key Innovations Transforming the Sartans Industry?
4. Which Region Is Leading the Sartans Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Sartans Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 4060662 • Views: …
More Releases from The Business Research Company
Global Factors Influencing the Rapid Evolution of the Robotic Flight Simulator S …
The robotic flight simulator surgery market is on the verge of significant expansion as advanced technologies continue to reshape surgical training and planning. Driven by increasing adoption of virtual reality and innovative simulation tools, this sector is set to experience considerable growth over the coming years. The following analysis explores the market's valuation, key contributors, evolving trends, and the segmentation landscape.
Projected Market Size and Growth Trajectory of the Robotic Flight…
Leading Companies Consolidating Their Presence in the Responsible Artificial Int …
As artificial intelligence (AI) technologies continue to evolve and integrate deeply into business operations, the need for transparent and accountable AI practices has never been more critical. The responsible artificial intelligence (AI) reporting packs market is emerging as a vital sector dedicated to ensuring that AI systems are monitored, governed, and reported with rigor. Let's explore the expected growth, key players, industry trends, and market segments shaping this important field.
Projected…
Future Perspective: Key Trends Shaping the Regenerative Grid Simulator Market Up …
The regenerative grid simulator market is on track for significant expansion as technological advancements and increasing energy demands drive innovation. With rising focus on smart grids and electric vehicle infrastructure, this market is poised to transform energy testing and validation processes in the coming years. Here's an in-depth look at the market's size, key players, emerging trends, and major segments shaping its future.
Forecast and Market Size Growth in the Regenerative…
Analysis of Key Market Segments Driving the Quic-Enabled Content Delivery Networ …
The quic-enabled content delivery network edge industry is on track for remarkable expansion over the coming years. Driven by evolving digital needs and technological advancements, this market is set to transform how content is delivered and experienced globally. Let's explore its market size, key players, prevailing trends, and segment-specific forecasts to understand the future trajectory of this dynamic sector.
Projected Market Growth and Size of the Quic-Enable Content Delivery Network Edge…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
